Annovis Bio Inc. News, Annovis Bio Inc. Quote, ANVS Quote

Annovis Bio Inc. (NY:ANVS) Delayed: 1.86 -0.09 (4.62%)

Prev. Close

$1.95

Today 6M 1Y 5Y

Open

$1.93

52 Wk High

$0.04

52 Wk Low

$0.01

Day High

$1.98

Day Low

$1.82

P/E

N/A

EPS

$-0.03

Volume

1,166,603

Friends, Peers and Foes (?): TRAW, NTLA, RXRX, ZYME, ARQT (more...)

ALERTS | RSS

Jul 10, 2026 06:04 AM Form 8-K Annovis Bio, Inc. For: Jul 07
Jul 7, 2026 04:12 PM Roth/MKM Starts Annovis Bio Inc. (ANVS) at Buy
Jul 7, 2026 07:00 AM Annovis Bio completes enrollment of 850 patients in Phase 3 AD trial
Jul 7, 2026 07:00 AM Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease
Jul 1, 2026 08:02 AM Annovis Bio names Cheng Fang as chief scientific officer
Jul 1, 2026 08:00 AM Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer
Jun 17, 2026 04:51 PM Form 8-K Annovis Bio, Inc. For: Jun 17
May 26, 2026 08:01 AM Annovis Bio regains NYSE listing compliance
May 26, 2026 08:00 AM Annovis Bio Regains NYSE Listing Compliance
May 21, 2026 08:11 PM Form 4 Annovis Bio, Inc. For: May 20 Filed by: Hoffman Michael B

Entities mentioned with ANVS

View All Entities